Table 4.
Predicted toxicology and pharmacological properties by ADMET analysis.
| Ligand | Benigni/Bossa rules | AMES test | Lipinski's rule of five | Skin corrosive | ||
|---|---|---|---|---|---|---|
| Carcinogenicity | Mutagenicity | Violation | Druglikeness | |||
| Fisetin | Noncarcinogenic | Nonmutagenic | Pass | 0 | Yes | No |
| Galangin | Noncarcinogenic | Nonmutagenic | Pass | 0 | Yes | No |
| Hesperetin | Noncarcinogenic | Nonmutagenic | Pass | 0 | Yes | No |
| Hesperidin | Noncarcinogenic | Nonmutagenic | Pass | 4 | No | Yes |
| Myricetin | Noncarcinogenic | Nonmutagenic | Pass | 1 | Yes | No |
| Naringenin | Noncarcinogenic | Nonmutagenic | Pass | 0 | Yes | No |
| Quercetin | Noncarcinogenic | Nonmutagenic | Pass | 0 | Yes | No |